Thymocyte apoptosis induced by p53-dependent and independent pathways.

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95

Bcl-2 and the regulation of programmed cell death. J Cell Biol (1994) 7.88

Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev (2000) 5.90

p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci U S A (1994) 5.49

The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (1998) 5.40

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A (1994) 5.11

A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med (1999) 4.15

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol (1994) 4.14

Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev (1998) 3.92

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med (2006) 3.78

A continuum model for tumour suppression. Nature (2011) 3.48

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J (2002) 3.45

Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev (2001) 3.41

The molecular biology of apoptosis. Proc Natl Acad Sci U S A (1996) 3.39

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19

Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci U S A (2001) 3.16

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci U S A (1999) 3.13

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12

PUMA, a potent killer with or without p53. Oncogene (2008) 3.09

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91

Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A (1995) 2.78

The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol (2006) 2.77

Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol (1997) 2.71

Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J (1996) 2.63

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A (1994) 2.63

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62

Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell (2012) 2.62

Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61

Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc Natl Acad Sci U S A (1996) 2.58

BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood (2005) 2.54

In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50

Integral role of Noxa in p53-mediated apoptotic response. Genes Dev (2003) 2.50

Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish. Genes Dev (2005) 2.44

Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J (1994) 2.43

A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol Cell (2009) 2.41

DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol (2012) 2.39

p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J (2000) 2.38

Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci U S A (1994) 2.37

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32

A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci U S A (2005) 2.32

Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A (1996) 2.30

Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc Natl Acad Sci U S A (2002) 2.24

Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol Cell Biol (1999) 2.22

Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J (1993) 2.21

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14

Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol (1994) 2.14

The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet (2012) 2.13

Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol (2009) 2.10

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10

Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol (1994) 2.06

p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell (2012) 2.04

Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol (1996) 2.03

Induction of apoptosis by the transcription factor c-Jun. EMBO J (1997) 2.02

Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med (1999) 2.01

The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells. Mol Cell Biol (1993) 2.01

20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer (2009) 2.00

Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol (1996) 1.98

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96

Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect (1995) 1.95

Role of cysteine residues in regulation of p53 function. Mol Cell Biol (1995) 1.91

Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91

Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol Cell Biol (2004) 1.85

Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J (1995) 1.85

Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A (1997) 1.82

In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ (2008) 1.81

NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A (2002) 1.80

Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci U S A (1995) 1.78

E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol (1998) 1.75

Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J (2002) 1.73

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J Exp Med (1997) 1.73

Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci U S A (2000) 1.72

Cancer. A death in the life of p53. Nature (1993) 1.70

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A (1999) 1.69

Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci U S A (1994) 1.69

Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci U S A (1996) 1.68

Mechanism of action for N-substituted benzamide-induced apoptosis. Br J Cancer (2002) 1.66

Irradiation selects for p53-deficient hematopoietic progenitors. PLoS Biol (2010) 1.65

Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol (2002) 1.65

Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med (1995) 1.65

Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med (1997) 1.64

Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64

Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J (2004) 1.63

Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol (1995) 1.62

Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J (1998) 1.62

Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med (1995) 1.59

Inhibition of apoptosis by the retinoblastoma gene product. EMBO J (1995) 1.58

The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol (1994) 1.58

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet (2002) 1.57

Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol (1994) 1.56

Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med (1996) 1.56

Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J (1994) 1.54

Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci U S A (2002) 1.54

Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol (2009) 1.51

p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest (1997) 1.51

Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev (2010) 1.51

Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol (1994) 1.50

Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74

Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69

Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95

Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79

Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci (2000) 8.20

Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66

Synaptic tagging and long-term potentiation. Nature (1997) 7.65

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature (1986) 7.10

Requirement for a functional Rb-1 gene in murine development. Nature (1992) 6.87

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67

Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature (1998) 6.29

Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (1988) 6.12

Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol (1987) 5.96

Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43

Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A (1973) 5.20

Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol (1991) 4.89

T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18

129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60

Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus (1999) 3.55

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet (1997) 3.42

Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A (1995) 3.42

Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41

Micromachining a miniaturized capillary electrophoresis-based chemical analysis system on a chip. Science (1993) 3.34

Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology (2001) 3.30

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature (2001) 3.28

Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell (1989) 3.20

Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci (2004) 3.10

Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys (1989) 3.07

Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07

Defying death after DNA damage. Nature (2000) 3.03

Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci (1998) 3.00

Consequences of the provision of laboratory services for the National Health Service by commercial firms: a view from the university sector. J Clin Pathol (1990) 2.99

Memory consolidation and NMDA receptors: discrepancy between genetic and pharmacological approaches. Science (2001) 2.97

Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat Genet (1993) 2.87

Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology (1985) 2.77

Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol (2009) 2.65

Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem (1983) 2.57

High-frequency developmental abnormalities in p53-deficient mice. Curr Biol (1995) 2.57

Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature (1995) 2.47

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45

Selective DNA conservation and chromatin assembly after injection of SV40 DNA into Xenopus oocytes. Dev Biol (1978) 2.43

White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology (2006) 2.42

Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta (1992) 2.33

Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32

Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain (2003) 2.32

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32

APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18

Impaired spatial learning after saturation of long-term potentiation. Science (1998) 2.17

Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci (2002) 2.05

Hippocampal representation in place learning. J Neurosci (1990) 2.05

Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol (1982) 2.04

The enigma of olfactory learning. Trends Neurosci (1993) 2.02

Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp (1999) 2.01

Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol (1991) 1.98

A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging (2007) 1.92

Accuracy of reporting of family history of colorectal cancer. Gut (2004) 1.92

Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene (1994) 1.91

Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87

Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A (2001) 1.85

Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 1.84

Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol (1984) 1.83

The Edinburgh intercalated honours BSc in pathology: evaluation of selection methods, undergraduate performance, and postgraduate career. Br Med J (Clin Res Ed) (1986) 1.82

Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77

p53 expression in colorectal tumors. Am J Pathol (1991) 1.77

The functional neuroanatomy of comprehension and memory: the importance of prior knowledge. Brain (1999) 1.74

Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry (2004) 1.72

Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70

Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70

p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene (1994) 1.69

Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg (2008) 1.67

Landmark stability is a prerequisite for spatial but not discrimination learning. Nature (1993) 1.66

A multichamber equilibrium dialysis apparatus. Anal Biochem (1972) 1.61

Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions. Exp Brain Res (1985) 1.59

Aetiologic factors in lymphoid malignancies: a case-control epidemiological study. Leuk Res (1984) 1.57

Weak before strong: dissociating synaptic tagging and plasticity-factor accounts of late-LTP. Neuropharmacology (1999) 1.57

Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. J Clin Pathol (1987) 1.56

Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci U S A (1994) 1.55

Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol (1998) 1.55

The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci (1992) 1.54

Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. Q J Exp Psychol B (1986) 1.53

High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene (1989) 1.52